Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Cystinosis

• PK and PD Study of NPI-001 and Cysteamine Bitartrate
• Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor
• Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)
• A Phase 2 Study of ELX-02 in Patients With Nephropathic Cystinosis
• Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis
• Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis
• Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in Cystinosis
• N Acetyl Cysteine for Cystinosis Patients
• Study in Healthy Adults to Determine the Effect That Food Has on the Absorption and Delivery of the Drug Cystagon™
• Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)
• Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis
• Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis
• Use of Cysteamine in the Treatment of Cystinosis
• Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis
• New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis
• Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis